Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Docosahexaenoic Acid (DHA) For The Treatment of Pediatric Concussion Related to Sports Injury

NCT01903525 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.

NCT NCT01903525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01903525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Docosahexaenoic Acid (DHA) For The Treatment of Pediatric Concussion Related to Sports Injury
Lead sponsor
University of Texas Southwestern Medical Center
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2013
Completion date
August 31, 2017
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

concussion, mild traumatic brain injury